Charles Bennett to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications Charles Bennett has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
1.006
-
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Bone Marrow Transplant. 2016 Feb; 51(2):277-82.
Score: 0.419
-
Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999 Sep; 24(5):555-60.
Score: 0.137
-
A review of the costs, cost-effectiveness and third-party charges of bone marrow transplantation. Stem Cells. 1996 May; 14(3):312-9.
Score: 0.108
-
Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016 Sep; 51(9):1228-32.
Score: 0.108
-
Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. 2007 Aug; 40(3):185-92.
Score: 0.059
-
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007 Apr; 39(7):425-9.
Score: 0.057
-
Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995. Bone Marrow Transplant. 1999 Sep; 24(6):679-84.
Score: 0.034
-
Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know? Bone Marrow Transplant. 1998 Apr; 21(7):641-50.
Score: 0.031
-
Economic analyses of new technologies: the case of stem-cell transplantation. J Clin Oncol. 1997 Jan; 15(1):2-4.
Score: 0.028
-
Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991. J Clin Oncol. 1995 Apr; 13(4):969-73.
Score: 0.025